Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma von LEMIEUX, B, TARTAS, S, TRAULLE, C, ESPINOUSE, D, THIEBLEMONT, C, BOUAFIA, F, ALHUSEIN, Q, ANTAL, D, SALLES, G, COIFFIER, B

Volltext

Impact of neoadjuvant chemotherapy on therapeutic management of muscle-invasive bladder cancer von Meyer, V, Flechon, A, Tartas, S, Fassi-Fehri, H, Ruffion, A, Martin, X, Colombel, M

Volltext

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma von Rini, Brian I, Plimack, Elizabeth R, Stus, Viktor, Gafanov, Rustem, Hawkins, Robert, Nosov, Dmitry, Pouliot, Frédéric, Alekseev, Boris, Soulières, Denis, Melichar, Bohuslav, Vynnychenko, Ihor, Kryzhanivska, Anna, Bondarenko, Igor, Azevedo, Sergio J, Borchiellini, Delphine, Szczylik, Cezary, Markus, Maurice, McDermott, Raymond S, Bedke, Jens, Tartas, Sophie, Chang, Yen-Hwa, Tamada, Satoshi, Shou, Qiong, Perini, Rodolfo F, Chen, Mei, Atkins, Michael B, Powles, Thomas

Volltext

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial von Kerbrat, Pierre, Fumoleau, Pierre, Jacquin, Jean-Philippe, Abadie-Lacourtoisie, Sophie, Cany, Laurent, Khayat, David, Paget-Bailly, Sophie, Demarchi, F, N'Guyen, T, Stein, U, Villanueva, C, Guimont, I, Lévy, E, Delbaldo, C, Pouessel, D, Fournel-Fédérico, C, Freyer, G, Tartas, S, Bons, F, Cuvier, C, Hajjaji, N, Capitain, O, Maillart, P, Bonnefoi, H, Durand, M, Madranges, N, Mauriac, L, Durando, X, Durieux, A, Piperno-Neumann, S, Tresca, P, Ferrant, E, Mayer, F, Vanneuville, AC, Servent, V, Guastalla, JP, Biron, P, Dupuy-Brousseau, L, Lancry, L, Trédan, O, Extra, JM, Berton-Rigaud, D, Ferrero, JM, Largillier, R, Gedoin, D, Laguerre, B, Lefeuvre, C, Vauléon, E, Tennevet, I, Mefti-Lacheraf, F, Dalenc, F, André, F, Domont, J, Ezenfis, J, Provençal, J, Bellaiche-Miccio, C, Boutan-Laroze, G, Arsène, O, Merad-Boudia, Z, Orfeuvre, H, Lamy, R, Sarda, C, Salles, B, Cauvin, I, Mangold, M, Bourcier, A, Geay, JF, ElAmarti, R, Combe, M, Dauba, J, Denizon, N, Clavreul, G, Goubely, Y, Delecroix, V, Ligeza-Poisson, V, Leyronnas, C, Teissier, E, Bernard, O, Pottier-Kyndt, V, Drony, S, Moriceau, M, Besson, D, Achille, E, Moran-Ribon, A, Moullet, I, Couderc, B, Burki, F, Schaeffer, F, Montcuquet, P, Baumont, GA, Gréget, S, Ratoanina, JL, Bonichon-Lamichhane, M, Cartron, G, Dupuis, O, Ganem, G, LeRol, A, Antoine, EC, Llory, JF, Loiseau, D

Volltext

Rituximab-dependent cytotoxicity by natural killer cells: Influence of FCGR3A polymorphism on the concentration-effect relationship von DALL'OZZO, Sébastien, TARTAS, Sophie, PAINTAUD, Gilles, CARTRON, Guillaume, COLOMBAT, Philippe, BARDOS, Pierre, WATIER, Hervé, THIBAULT, Gilles

Volltext

675P HER2 expression in circulating tumour cells is associated with poor outcomes in patients with metastatic castration resistant prostate cancer von Maillet, D., Allioli, N., Peron, J., Plesa, A., Decaussin, M., Tartas, S., Ruffion, A., Crouzet, S., Freyer, G., Vlaeminck-Guillem, V.

Volltext

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma von Choueiri, Toni K, Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Hajek, Jaroslav, Symeonides, Stefan N, Lee, Jae Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi B, Sawrycki, Piotr, Gurney, Howard, Chevreau, Christine, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Burke, John M, Doshi, Gurjyot, Topart, Delphine, Oudard, Stephane, Hammers, Hans, Kitamura, Hiroshi, Bedke, Jens, Perini, Rodolfo F, Zhang, Pingye, Imai, Kentaro, Willemann-Rogerio, Jaqueline, Quinn, David I, Powles, Thomas

Volltext

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer von Powles, Thomas, Valderrama, Begoña P., Gupta, Shilpa, Bedke, Jens, Kikuchi, Eiji, Hoffman-Censits, Jean, Iyer, Gopa, Vulsteke, Christof, Park, Se Hoon, Shin, Sang Joon, Castellano, Daniel, Fornarini, Giuseppe, Li, Jian-Ri, Gümüş, Mahmut, Mar, Nataliya, Loriot, Yohann, Fléchon, Aude, Duran, Ignacio, Drakaki, Alexandra, Narayanan, Sujata, Yu, Xuesong, Gorla, Seema, Homet Moreno, Blanca, van der Heijden, Michiel S.

Volltext

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy von Scher, Howard I, Fizazi, Karim, Saad, Fred, Taplin, Mary-Ellen, Sternberg, Cora N, Miller, Kurt, de Wit, Ronald, Mulders, Peter, Chi, Kim N, Shore, Neal D, Armstrong, Andrew J, Flaig, Thomas W, Fléchon, Aude, Mainwaring, Paul, Fleming, Mark, Hainsworth, John D, Hirmand, Mohammad, Selby, Bryan, Seely, Lynn, de Bono, Johann S

Volltext

Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a... von Grimm, Marc-Oliver, Esteban, Emilio, Barthélémy, Philippe, Schmidinger, Manuela, Busch, Jonas, Valderrama, Begoña P, Charnley, Natalie, Schmitz, Marc, Schumacher, Ulrike, Leucht, Katharina, Foller, Susan, Baretton, Gustavo, Duran, Ignacio, de Velasco, Guillermo, Priou, Frank, Maroto, Pablo, Albiges, Laurence

Volltext

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma von Choueiri, Toni K., Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Tom, Symeonides, Stefan N., Hajek, Jaroslav, Chang, Yen-Hwa, Lee, Jae-Lyun, Sarwar, Naveed, Haas, Naomi B., Gurney, Howard, Sawrycki, Piotr, Mahave, Mauricio, Gross-Goupil, Marine, Zhang, Tian, Burke, John M., Doshi, Gurjyot, Melichar, Bohuslav, Kopyltsov, Evgeniy, Alva, Ajjai, Oudard, Stephane, Topart, Delphine, Hammers, Hans, Kitamura, Hiroshi, McDermott, David F., Silva, Adriano, Winquist, Eric, Cornell, Jerry, Elfiky, Aymen, Burgents, Joseph E., Perini, Rodolfo F., Powles, Thomas

Volltext

Denosumab in patients with bone metastases from renal-cell carcinoma treated with anti-angiogenic therapy: a retrospective study from the GETUG (Groupe Etude des Tumeurs Uro Genita... von Guillot, A., Joly, C., Barthelemy, P., Meriaux, E., Negrier, S., Pouessel, D., Chevreau, C., Mahammedi, H., Houede, N., Roubaud, G., Gravis, G., Tartas, S., Albiges, L., Vassal, C., Oriol, M., Tinquaut, F., Espenel, S., Culine, S., Fizazi, K.

Volltext

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial von Pivot, Xavier, Prof, Romieu, Gilles, MD, Debled, Marc, MD, Pierga, Jean-Yves, Prof, Kerbrat, Pierre, Prof, Bachelot, Thomas, MD, Lortholary, Alain, MD, Espié, Marc, MD, Fumoleau, Pierre, Prof, Serin, Daniel, MD, Jacquin, Jean-Philippe, MD, Jouannaud, Christelle, MD, Rios, Maria, MD, Abadie-Lacourtoisie, Sophie, MD, Tubiana-Mathieu, Nicole, Prof, Cany, Laurent, MD, Catala, Stéphanie, MD, Khayat, David, Prof, Pauporté, Iris, PhD, Kramar, Andrew, PhD

Volltext

PIK-ORL: A phase II, multicenter trial aiming to evaluate BKM120 in monotherapy in patients (pts) with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC) after fail... von Fayette, J., Digue, L., Ferlay, C., Treilleux, I., Garin, G., Wang, Q., Hebert, C., Even, C., Cupissol, D., Couchon-Thaunat, S., Jaouen, L., Guyennon, A., Le Tourneau, C., Lefebvre, G., Mailliez, A., Matias, M., Degardin, M., Tartas, S., Clapisson, G., Perol, D.

Volltext

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma von Choueiri, Toni K., Powles, Thomas, Peltola, Katriina, de Velasco, Guillermo, Burotto, Mauricio, Suarez, Cristina, Ghatalia, Pooja, Iacovelli, Roberto, Lam, Elaine T., Verzoni, Elena, Gümüş, Mahmut, Stadler, Walter M., Kollmannsberger, Christian, Melichar, Bohuslav, Venugopal, Balaji, Gross-Goupil, Marine, Poprach, Alexandr, De Santis, Maria, Schutz, Fabio A., Park, Se Hoon, Nosov, Dmitry A., Porta, Camillo, Lee, Jae Lyun, Garcia-del-Muro, Xavier, Biscaldi, Elisa, Manneh Kopp, Ray, Oya, Mototsugu, He, Li, Wang, Aobo, Perini, Rodolfo F., Vickery, Donna, Albiges, Laurence, Rini, Brian

Volltext

A pyriform sinus cancer organ preservation strategy comprising induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil, followed by potentiated radiotherapy: a multice... von Céruse, Philippe, Cosmidis, Alain, Belot, Aurélien, Rabilloud, Muriel, Fuchsmann, Carine, Poupart, Marc, Ramade, Antoine, Tartas, Sophie, Favrel, Véronique, Pommier, Pascal, Zrounba, Philippe, Fayette, Jérôme

Volltext

Curative treatment can be an option for patients with metastatic squamous cell cancer of the head and neck von Guenne, Clémence, Fayette, Jérôme, Cosmidis, Alain, Fuchsmann, Carine, Tartas, Sophie, Favrel, Véronique, Céruse, Philippe

Volltext

Abstract P6-06-07: 5-year disease free-survival results of aggressively-treated breast cancer during pregnancy: Results from a French multicenter study von Vanlemmens, L, Delaloge, S, Ploquin, A, Bachelot, T, Frenel, J-S, Loustalot, C, Kerbrat, P, Mignot, L, Debled, M, Allouache, D, Vinceneux-Confavreux, A, Provansal, M, Dalenc, F, Mouret-Reynier, M-A, Lerebours, F, Jacot, W, Tartas, S, Morvan, F, Jebert, S, Decoupigny, E, Rouzier, R

Volltext

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Gr... von Lortholary, A., Largillier, R., Weber, B., Gladieff, L., Alexandre, J., Durando, X., Slama, B., Dauba, J., Paraiso, D., Pujade-Lauraine, E.

Volltext

Insuffisance corticotrope isolée sous anti-PD1 von Cugnet Anceau, C., Marchand, L., Amini-Adle, M., Maillet, D., Tartas, S., Dalle, S.

Volltext